Drawing for NEUCARDIN

USPTO serial 77754910

NEUCARDIN

Reviewed by CopyMark Law Group

Reg. 3734178Status 800Registered
Filing date
Status date
Registration date
Jan 5, 2010
Examiner
SHANAHAN, PATRICK
Law office
GENERIC WEB UPDATE

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with NEUCARDIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Yue (Robert) Xu

Yue (Robert) Xu Apex Attorneys at Law, LLP160 Alamo Plaza #942Alamo, CA 94507UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005(Based on Use in Commerce) Biological preparations for medical purposes; Cardiovascular pharmaceuticals; Cardiovascular treatment preparations; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the treatment of heart rhythm disorders; Synthetic peptides for the treatment of cardiovascular disease (Based on 44(e) Biological preparations for medical purposes; Cardiovascular pharmaceuticals; Cardiovascular treatment preparations; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the treatment of heart rhythm disorders; Synthetic peptides for the treatment of cardiovascular diseaseACTIVEJan 1, 2006

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 12, 2019NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Sep 12, 2019RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Sep 12, 201989AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Sep 12, 2019APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 7, 2019CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 7, 2019COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 29, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 29, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 31, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 31, 2019E89RTEAS SECTION 8 & 9 RECEIVED
Jan 5, 2019CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 5, 2019COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 5, 2019REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sep 15, 2015NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sep 15, 2015C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 14, 2015APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 12, 2015E815TEAS SECTION 8 & 15 RECEIVED
Jan 5, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 11, 2009CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 11, 2009COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 20, 2009NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 20, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 17, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 17, 2009ALIEASSIGNED TO LIE
Sep 9, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 9, 2009DOCKASSIGNED TO EXAMINER
Jun 12, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 12, 2009NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance